• About us
  • Investment profile
  • Investment partners
  • Investment approach
  • Portfolio
  • News and views
  • Contacts
Mackintosh Capital invests in and supports small and medium enterprises (SMEs) as a catalyst for realising their potential
← Oncimmune acquires dedicated commercial testing facility for EarlyCDT-Lung from Health Diagnostic Laboratory, Inc
Oncimmune floats in London →

Oncimmune announces intention to float

Posted on April 18, 2016 by admin

Oncimmune, the leading early cancer detection company has announced its intention to float on the London Stock Exchange. For more details, click: http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/other/12780225.html

Mackintosh Capital LLP, Mackintosh House, 136 Newport Road, Cardiff, CF24 1DJ | Tel: +44 (0)2921 25 1455
Copyright 2010 Mackintosh Capital LLP
All rights reserved

Terms of Use and Privacy Policy